Roquette Commits to BioPharma Market

PR67811

LESTREM, France, Mar. 15, 2017 /PRNewswire=KYODO JBN/ --

     Reinforces position as a supplier of excipients and raw materials for the

pharmaceutical and biopharmaceutical industries

    Roquette, a global leader in innovative plant-based pharmaceutical

ingredients, announces its commitment to provide new product offerings to

address the growing demand for excipients and raw materials for the

biopharmaceutical market.

(Logo: http://mma.prnewswire.com/media/478344/Roquette_Logo.jpg )

    New product offerings are low endotoxin, multi-compendial grade materials

for cell culture and biologic drug formulations.These products extend

Roquette's commitment to helping customers save and sustain patient's lives.

    "As a long-time leader in excipients and active ingredients for the

pharmaceutical market, Roquette is proud to be part of this major therapeutic

progress and is excited to introduce several new products in the U.S., Europe

and Asia," said Paul Smaltz, VP of Global Business Unit Pharma.

    "We have three new brands coming to the market under the names LYCADEX(R)

BioPharma dextrose, PEARLITOL(R) BioPharma mannitol and NEOSORB(R) BioPharma

sorbitol with a plan to continue adding to the portfolio," said Kelsey

Achenbach, Pharma Marketing Director. "Customers now have an alternative option

with a partner who is an established manufacturer and has sole custody of the

supply chain when it comes to materials for biopharmaceuticals."

    This investment reaffirms the company's strategic initiatives to develop

specialties for Pharma, Food, Nutrition and Health markets to accelerate global

growth. The BioPharma market launch addresses the growing customer demand for

biologic drugs worldwide. These protein-based drugs can be game-changing by

having the ability to put rheumatoid arthritis into remission and transform

many cancers into treatable conditions.

    Consider Roquette, the bioLOGICAL choice.

    To learn more about Roquette biopharma offerings visit

https://www.roquette.com/pharma/biopharma.

    About Roquette:

    A family-owned Group serving customers globally, Roquette is a leader in

specialty food ingredients and pharmaceutical excipients. The products and

solutions developed by the Group deliver proven technological, nutritional and

health benefits precisely tailored to the pharma, nutrition, food and selected

industry markets. Roquette's offer is produced from plant-based raw materials

such as corn, wheat, potatoes and peas. Since its foundation over 80 years ago,

the Group's growth has been based on innovation, a passion for the job and a

commitment to achieve. Roquette operates in over 100 countries, has a turnover

of around 3.3 billion euros and currently employs more than 8,000 people

worldwide.

    http://www.roquette.com

SOURCE: Groupe ROQUETTE